China’s vaccine landscape is shifting after local biotech Xiamen Innovax Biotech unveiled the country’s first domestically ...

Merck is a massive company with strong fundamentals and underlying value at a heavily discounted price. Click here to find ...

Merck & Co., Inc. (NYSE: MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for the prevention ...

RFK Jr.’s vaccine panel endorsed Merck’s RSV shot for babies, easing fears that his stance might delay rollout.

Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments ...

Merck (MRK) stock gains as CDC's draft agenda for an upcoming meeting excludes HPV vaccine dose changes, favoring the company's Gardasil vaccine. Read more here.

Merck Manuals launches AI-powered search, offering patients fast, trusted answers from its widely used medical manuals and resources.

Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat head and neck cancers.

Merck & Co. won US approval for a shot that protects against RSV, the most common cause of hospitalization among infants.

Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.